Sickle cell treatment cleared for use derived from OKC researcher's discoveriesPublished: Wednesday, November 20, 2019 By: Steve Lackmeyer Source: NewsOK
A new drug that treats sickle cell disease based on discoveries by Oklahoma Medical Research Foundation scientist Rodger McEver is now cleared to be used at hospitals and clinics.
The U.S. Food and Drug Administration gave Novartis approval Friday to produce the drug therapy, known as Adakveo, following a 52-week clinical trial showing treatment with the drug led to a significant reduction in pain crises for sickle cell patients.
Adakveo is expected to be available in hospitals and clinics in coming weeks.
“I’ve treated sickle cell patients, and their suffering is extreme,” said McEver, a hematologist and OMRF’s vice president of research. “It’s the dream of every physician, and certainly every scientist, to do something that can make a difference with patients.”
Read the story on NewsOK.com.